Teleflex Akcija

Teleflex EBIT augimas

Teleflex (TFX) Metinis EBIT augimas 2026-08-25 dieną yra 60,86 %. Praėjusiais metais Metinis EBIT augimas buvo −68,59 % — pokytis −188,73% (didesnis).

EBIT augimas

60,86 %

YoY

−188,73%

Paskutinį kartą atnaujinta:

Teleflex Metinis EBIT augimas yra 2026 60,86 % . Teleflex Metinis EBIT augimas buvo 2025 −68,59 % . Tai sumažėjo −188,73% didesnis lyginant su praėjusiais metais.

Teleflex EBIT augimas istorija

  • 3 metų

  • 10 metų

  • 25 metų

  • Max

EBIT augimas
Date
EBIT augimas
2018-01-01
−13,59 USD
2019-01-01
32,81 USD
2020-01-01
−0,98 USD
2021-01-01
48,46 USD
2022-01-01
−20,44 USD
2023-01-01
1,32 USD
2024-01-01
−68,59 USD
2025-01-01
60,86 USD
Teleflex EBIT augimas istorija
METAIEBIT augimasYoY
60,86 %−188,73%
−68,59 %−5 302,98%
1,32 %−106,45%
−20,44 %−142,17%
48,46 %−5 046,38%
−0,98 %−102,99%
32,81 %−341,51%
−13,59 %−182,15%
16,54 %+1 366,51%
1,13 %−89,65%
10,89 %
Access this data via the Eulerpool API

Teleflex Akcijų analizė

Ką veikia Teleflex? Teleflex Inc. is a global company founded in 1943. The company is headquartered in Wayne, Pennsylvania, USA and operates in over 40 countries worldwide. It is a leading provider of medical devices, instruments, and accessories for various applications in clinical practice and patient care. The business model of Teleflex is based on the manufacturing and marketing of medical devices and instruments, particularly in the areas of anesthesia, vascular access, interventional medicine, pulmonary and thoracic surgery, urological care, cardiovascular diagnostics, and surgery. The company works closely with medical professionals and clinicians to develop high-quality products that meet the needs of patients and doctors. Teleflex is divided into several business segments, including angiography/diagnostics, anesthesia, oncology, vascular intervention, pulmonology, surgery, and urology. Each of these segments offers a wide range of products and solutions specifically tailored to the needs of doctors and patients. In the angiography/diagnostics segment, Teleflex offers a variety of products that can be used for the diagnosis and treatment of cardiovascular diseases and other medical conditions. These include catheters, guide wires, and sheaths. The anesthesia segment of Teleflex includes products such as ventilation bags, endotracheal tubes, and nebulizer systems. These products are essential for the successful performance of anesthesia procedures and can help doctors save valuable time and resources. The oncology segment of Teleflex offers a wide range of products specifically designed for the treatment of cancer patients. These include catheter-based systems that can facilitate the administration of drugs and other therapies. With the vascular intervention segment, Teleflex offers a comprehensive range of products and solutions specifically designed for the treatment of vascular diseases. These include balloon catheters, stents, and sheaths. The pulmonology segment of Teleflex offers products aimed at facilitating breathing and improving the quality of life for patients with chronic respiratory diseases. These include oxygen concentrators, tracheal tubes, and ventilators. The surgical segment of Teleflex offers a variety of solutions for performing surgical procedures, including surgical instruments, sutures, and wound care materials. The urology segment of Teleflex offers a wide range of products specifically designed for use in urology. These include catheters, wires, and stents. Teleflex is a leading company in the medical technology industry that specializes in the development and marketing of products that improve patients' quality of life and facilitate the work of doctors. With its innovative solutions and a focus on providing the best possible customer service and patient safety, Teleflex has taken on a significant role in the industry and will continue to be an important provider in this market in the future. Teleflex yra viena populiariausių kompanijų Eulerpool.com.

Dažniausiai užduodami klausimai apie Teleflex akciją

Teleflex Metinis EBIT augimas 2026 m. yra 60,86 %.

Eulerpool rasite visą Metinis EBIT augimas Teleflex istorinę raidą nuo 2006 m. – su metinėmis reikšmėmis, grafikais ir išsamiomis analizėmis.

EBIT augimas matuoja procentinį operacinio pelno pokytį. Jis parodo, ar pagrindinis verslo pelniningumas auga.

Norėdami įvertinti Metinis EBIT augimas, svarbu jį palyginti su toje pačioje pramonėje veikiančiais konkurentais. Eulerpool platformoje galite rasti tiesioginius pramonės palyginimus Metinis EBIT augimas.

Metinis EBIT augimas yra svarbus investuotojams veiksnys. Šios rodiklio pokyčiai gali signalizuoti apie pagerintas ar pablogėjusias finansines sąlygas, tiesiogiai paveikdami akcijos kainą. Eulerpool platformoje galite sekti Metinis EBIT augimas Teleflex istorinę raidą ir realią laiko informaciją.

Access this data via the Eulerpool API

Augimas — Teleflex

Visi pagrindiniai rodikliai — Teleflex